These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8292345)

  • 1. Enhanced proliferation of peripheral blood mononuclear cells and tumor-infiltrating lymphocytes in a plasma-derived cell culture fluid.
    Torres AR; Burger R; Rich A; Spendlove R; Warren RP
    Biotechniques; 1993 Dec; 15(6):1106-9. PubMed ID: 8292345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation and phenotype of bovine mononuclear leukocytes in cultures stimulated by pokeweed mitogen.
    Franklin ST; Young JW; Nonnecke BJ
    J Dairy Sci; 1994 Dec; 77(12):3592-600. PubMed ID: 7699137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
    Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
    Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
    Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
    Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta.
    Somasundaram R; Jacob L; Swoboda R; Caputo L; Song H; Basak S; Monos D; Peritt D; Marincola F; Cai D; Birebent B; Bloome E; Kim J; Berencsi K; Mastrangelo M; Herlyn D
    Cancer Res; 2002 Sep; 62(18):5267-72. PubMed ID: 12234995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
    Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T
    Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple technique for examining lymphocyte blastogenesis in whole blood cultures for neonatal calves.
    Whitbread TJ; Rowan TG
    Res Vet Sci; 1986 Mar; 40(2):161-5. PubMed ID: 3704334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pokeweed-mitogen induced lymphocyte proliferation: the effect of stimulation on mononuclear phagocytic cells.
    de Vries E; Lafeber GJ; van der Weij JP; van Buijsen AC; Leijh PC; Cats A
    Immunology; 1980 Jun; 40(2):177-82. PubMed ID: 7409856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host soluble factors that regulate the synthesis of the major core protein of the bovine leukemia virus (BLV) in a naturally infected neoplastic B-cell line.
    Gutiérrez S; Ceriani C; Juliarena M; Ferrer JF
    Vet Immunol Immunopathol; 2009 Oct; 131(3-4):246-58. PubMed ID: 19497626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7.1 immunogene therapy effectively activates CD(4+) tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy.
    Ando H; Saio M; Ohe N; Tamakawa N; Yu H; Nakayama T; Yoshimura S; Kaku Y; Iwama T; Shinoda J; Sakai N; Takami T
    Int J Oncol; 2002 Apr; 20(4):807-12. PubMed ID: 11894129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phorbol dibutyrate and ionomycin improve murine effector cell cytotoxicity.
    Hamby LS; Freeman JW; McGrath PC
    J Surg Res; 1993 Feb; 54(2):115-21. PubMed ID: 8479168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The participation of human peripheral blood lymphocytes with Fc receptors for IgG or IgM in the fetal bovine serum induction of amplifier cell activity.
    Golightly MG; Zielske JV; Golub SH
    J Clin Lab Immunol; 1980 Nov; 4(3):181-8. PubMed ID: 6970819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
    Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
    J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of fibrogenic cytokines by interleukin-2-treated peripheral blood leukocytes: expression of transforming growth factor-beta and platelet-derived growth factor B chain genes.
    Kovacs EJ; Brock B; Silber IE; Neuman JE
    Obstet Gynecol; 1993 Jul; 82(1):29-36. PubMed ID: 8515922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.
    Lamers CH; Willemsen RA; Luider BA; Debets R; Bolhuis RL
    Cancer Gene Ther; 2002 Jul; 9(7):613-23. PubMed ID: 12082462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumor-infiltrating lymphocytes and lymphokine-activated killer cells.
    Wallace PK; Palmer LD; Perry-Lalley D; Bolton ES; Alexander RB; Horan PK; Yang JC; Muirhead KA
    Cancer Res; 1993 May; 53(10 Suppl):2358-67. PubMed ID: 8485722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.